Given melatonin’s neuroprotective effects -such as reducing amyloid-beta production, mitigating tau hyperphosphorylation, alleviating oxidative stress, and enhancing blood-brain barrier function- its dysregulation may further link poor sleep health to increased dementia risk45. The gene discussed is MAPT; the disease is dementia.